NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Medicines Update

For all prescribers and health professionals both in primary care and the acute sector.

All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site.  Click here for an index to all previous editions.  If you would like a copy of a previous edition, please contact  medicines.update@ggc.scot.nhs.uk

Creon 40 000 Unavailable

Posted: April 10, 2015.
Category - Medicines Update

The manufacturer of Creon® (pancreatin) has advised that patients currently prescribed the 40 000 strength are likely to have difficulty obtaining it from mid April 2015. There is no indication when it will be available again.  ...

Read More...

Gabapentin and pregabalin: risk of misuse:

Posted: April 10, 2015.
Category - Medicines Update
Tagged with - Prescribing

Public Health England recently published “Advice for prescribers on the risk of the misuse of&...

Read More...

Safe prescribing of corticosteroid eye drops

Posted: March 27, 2015.
Category - Medicines Update
Tagged with - Eye

Potential patient safety concerns were raised to East Dunbartonshire prescribing group relating to patients inadvertently continuing to use corticosteroid eye drops beyond the recommended duration. A local audit of patients after catara...

Read More...

Neuropathic Pain Guidelines Updated

Posted: March 09, 2015.
Category - Medicines Update
Tagged with - Guidelines Update

The updated NHSGGC Chronic Non-...

Read More...

Controlled Drugs and Patients' Ability to Drive

Posted: March 06, 2015.
Category - Medicines Update
Tagged with - Opioids Benzodiazepines

The Department for Transport has introduced a new offence of driving with certain controlled drugs (CDs) above specified limits in the blood; this legislation<...

Read More...

Sodium Oxybate (Xyrem): now schedule 2 CD

Posted: February 23, 2015.
Category - Medicines Update

On 7 January 2015, sodium oxybate (Xyrem®) was rescheduled as a Schedule 2 Controlled Drug (CD POM). It was previously a Schedule 4 Part 1 CD. This drug is licensed for the treatment of narcolepsy with cataplexy in adult patients, but was n...

Read More...

Opioid patches: safe conversion from oral therapy

Posted: February 23, 2015.
Category - Medicines Update
Tagged with - Opioids

Buprenorphine patches are available as BuTrans® and Transtec® patches. The Scottish Medicines Consortium concluded that buprenorphine patches were not cost-effective in the treatment of severe opioid responsive pain cond...

Read More...

Diabetes: HbA1c as a diagnostic test

Posted: February 23, 2015.
Category - Medicines Update
Tagged with - Diabetes

NHSGGC has adopted the WHO recommendation for the use of HbA1c as a diagnostic tool for diabetes. Guidance is included in the updated Read More...

ADTC update February 2015

Posted: February 23, 2015.
Category - Medicines Update
Tagged with - Respiratory

The additions to NHSGGC Formulary agreed at ADTC, 16 February 2015, included: Brimonidine gel (Mirvaso®) for the treatment of the erythema associated with rosacea. Brimonidine reduces erythema through direct cutaneous vasocon...

Read More...

Valproate for epilepsy or bipolar disorder: Risk of abnormal pregnancy outcomes

Posted: February 06, 2015.
Category - Medicines Update

The MHRA has published new information and strengthened warnings related to safety of medicines related to valproate (sodium valproate, valproic acid and valproate semisodium).   Valproate is associated with a dose-dependen...

Read More...